Furthermore, the study was restricted to diabetes patients under the age of 30, using insulin therapy, using proton pump inhibitors or H2 receptor blockers, consuming alcohol, having type 1 diabetes mellitus (T1DM) or secondary diabetes, suffering from inflammatory bowel disease, and having previously undergone gastrectomy or bariatric surgery. This evidence concerns the gene INS and type 1 diabetes mellitus.